Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

A Twist Bioscience executive, Dennis Cho, sold 1,507 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Dennis Cho, a Senior Vice President at Twist Bioscience, sold 1,507 shares of common stock on November 11, 2024.
• The sale was executed at a price of $47.998 per share.
• This transaction was not a discretionary trade but was mandated by the company's equity incentive plan to cover tax withholding obligations.
• Following the transaction, Dennis Cho directly owns 91,163 shares of Twist Bioscience stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is not indicative of any positive or negative sentiment towards the company's performance or future prospects.

Management Comments

• The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for companies to have 'sell to cover' policies to manage tax obligations.

Comparison to Industry Standards

• Many companies use 'sell to cover' mechanisms for stock-based compensation, so this is a standard practice.
• The transaction is similar to those of other executives at publicly traded companies who receive stock options or restricted stock units.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Twist Bioscience, stock sale, insider trading, tax obligations, equity incentive plan, restricted stock units